UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

Upper and lower limb muscle activation is bidirectionally and ipsilaterally coupled

Medicine and science in sports and exercise, 2009-09, Vol.41 (9), p.1778-1789

2009

Volltextzugriff (PDF)

Ultrasensitive detection of BRAF V600E mutations in circulating tumor DNA of patients with metastatic thyroid cancer

Endocrine, 2022-05, Vol.76 (2), p.491-494

2022

Volltextzugriff (PDF)

Hormonal modulation of ESR1 mutant metastasis

Oncogene, 2021-02, Vol.40 (5), p.997-1011

2021

Volltextzugriff (PDF)

Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers

Cancer, 2021-02, Vol.127 (3), p.391-402

2021

Volltextzugriff (PDF)

Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases

Breast cancer research and treatment, 2019-11, Vol.178 (2), p.251-261

2019

Volltextzugriff (PDF)

Correction to: Hormonal modulation of ESR1 mutant metastasis

Oncogene, 2022-01, Vol.41 (3), p.460-460

2022

Volltextzugriff (PDF)

Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced Cancers

JCO precision oncology, 2022-07, Vol.6, p.e2100512

2022

Volltextzugriff (PDF)

Moving the arms to activate the legs

Exercise and sport sciences reviews, 2006-07, Vol.34 (3), p.113-120

2006

Volltextzugriff (PDF)

Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH -Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors

JCO precision oncology, 2022-02, Vol.6, p.e2100197

2022

Volltextzugriff (PDF)

MEKK3 expression correlates with nuclear factor κ B activity and with expression of antiapoptotic genes in serous ovarian carcinoma

Cancer, 2009-09, Vol.115 (17), p.3897-3908

2009

Volltextzugriff (PDF)

Genomically informed longitudinal monitoring of circulating tumor DNA (ctDNA) to predict outcomes of cancer therapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3533-3533

2020

Volltextzugriff (PDF)

CT-based radiogenomic signature to identify isocitrate dehydrogenase (IDH)1/2 mutations in advanced intrahepatic cholangiocarcinoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4081-4081

2019

Volltextzugriff (PDF)

Liquid biopsies of plasma exosomal nucleic acids, plasma cell-free DNA, and survival of patients with advanced cancers

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11551-11551

2017

Volltextzugriff (PDF)

Mutation enrichment next-generation sequencing for quantitative detection of KRAS mutations in urine cell-free DNA from patients with advanced colorectal and other cancers

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.602-602

2017

Volltextzugriff (PDF)

MEKK3 EXPRESSION CORRELATES WITH NFκB ACTIVITY AND WITH EXPRESSION OF ANTI-APOPTOTIC GENES IN SEROUS OVARIAN CARCINOMA

Cancer, 2009-09, Vol.115 (17), p.3897-3908

2009

Volltextzugriff (PDF)

Upper and Lower Limb Muscle Activation Is Bidirectionally and lpsilaterally Coupled

Medicine and science in sports and exercise, 2009, Vol.41 (9), p.1778-1789

2009

Volltextzugriff (PDF)

Ultra-deep next-generation sequencing of plasma cell-free (cf) DNA from patients with advanced cancers

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e22168-e22168

2015

Volltextzugriff (PDF)

Ultra-deep next-generation sequencing of plasma cell-free (cf) DNA from patients with advanced cancers

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.11537-11537

2016

Volltextzugriff (PDF)

Low frequency KRAS G12/13 mutations in urine cell-free (cf) DNA from patients with BRAF V600E-mutant advanced cancers

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.11048-11048

2015

Volltextzugriff (PDF)

BRAF mutation testing in cell-free DNA from plasma of patients with advanced cancers using a novel, rapid, automated molecular diagnostics platform (Idylla)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e22139-e22139

2014

Volltextzugriff (PDF)

BRAF mutation testing with a novel, rapid, fully automated molecular diagnostics prototype platform

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.11086-11086

2013

Volltextzugriff (PDF)

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Journal of clinical oncology, 2019-06, Vol.37 (16), p.1380-1390

2019

Volltextzugriff (PDF)

Artificial intelligence meets medical robotics

Science (American Association for the Advancement of Science), 2023-07, Vol.381 (6654), p.141-146

2023

Volltextzugriff (PDF)

The Lancet Commission on global mental health and sustainable development

The Lancet (British edition), 2018-10, Vol.392 (10157), p.1553-1598

2018

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Aktive Filter

ThemaMale

KollektionRCN full-text journals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(131)

Publikationsform

Artikel
(162)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(100)
Life Sciences & Biomedicine
(81)
Humans
(74)
Female
(27)
Biological And Medical Sciences
(22)
Animals
(21)
Oncology
(21)
Adult
(20)
Multidisciplinary Sciences
(20)
Science & Technology - Other Topics
(20)
Tumors
(20)
Middle Aged
(16)
General & Internal Medicine
(15)
Aged
(14)
Mutation
(14)
Medicine, General & Internal
(13)
Medical Sciences
(12)
Mice
(12)
Patients
(12)
Cancer
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Upper and lower limb muscle activation is bidirectionally and ipsilaterally coupled

Ultrasensitive detection of BRAF V600E mutations in circulating tumor DNA of patients with metastatic thyroid cancer

Hormonal modulation of ESR1 mutant metastasis

Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers

Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases

Correction to: Hormonal modulation of ESR1 mutant metastasis

Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced Cancers

Moving the arms to activate the legs

Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH -Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors

MEKK3 expression correlates with nuclear factor κ B activity and with expression of antiapoptotic genes in serous ovarian carcinoma

Genomically informed longitudinal monitoring of circulating tumor DNA (ctDNA) to predict outcomes of cancer therapy

CT-based radiogenomic signature to identify isocitrate dehydrogenase (IDH)1/2 mutations in advanced intrahepatic cholangiocarcinoma

Phase I Study of the Combination of Vemurafenib, Carboplatin, and Paclitaxel in Patients with BRAF-Mutated Melanoma and Other Advanced Malignancies

Liquid biopsies of plasma exosomal nucleic acids, plasma cell-free DNA, and survival of patients with advanced cancers

Mutation enrichment next-generation sequencing for quantitative detection of KRAS mutations in urine cell-free DNA from patients with advanced colorectal and other cancers

MEKK3 EXPRESSION CORRELATES WITH NFκB ACTIVITY AND WITH EXPRESSION OF ANTI-APOPTOTIC GENES IN SEROUS OVARIAN CARCINOMA

Upper and Lower Limb Muscle Activation Is Bidirectionally and lpsilaterally Coupled

Ultra-deep next-generation sequencing of plasma cell-free (cf) DNA from patients with advanced cancers

Ultra-deep next-generation sequencing of plasma cell-free (cf) DNA from patients with advanced cancers

Low frequency KRAS G12/13 mutations in urine cell-free (cf) DNA from patients with BRAF V600E-mutant advanced cancers

BRAF mutation testing in cell-free DNA from plasma of patients with advanced cancers using a novel, rapid, automated molecular diagnostics platform (Idylla)

BRAF mutation testing with a novel, rapid, fully automated molecular diagnostics prototype platform

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Artificial intelligence meets medical robotics

The Lancet Commission on global mental health and sustainable development

Aktive Filter

Suchergebnisse filtern